RCOR2 and breast cancer: Depletion of CD4+ T cells, CD8+ T cells, or both with anti-CD4/CD8 neutralizing antibodies effectively restored RCOR2-KO1 tumors in the murine TUBO mammary tumor model (Supplemental Figure 2D).